News & Events
EAG Life Sciences Welcomes New Leadership
November, 2011, Maryland Heights, MO - Evans Analytical Group (EAG), the world's leading fully integrated independent laboratory network, appointed Craig Morley as General Manager of their Life Sciences Division. EAG Life Sciences provides analytical research and drug development support for the pharmaceutical, biotech and medical device industries. Morley brings over 20 years' experience in the
Life Sciences and CRO industries. Most recently, he has been in senior management roles with both Covance and leading the bioanalytical CRO business at Merck/Millipore.
"The addition of talented and seasoned executives such as Craig to our management team demonstrates our commitment to growing the EAG Life Sciences division and supporting our clients' needs for delivering quality research," said Harry Davoody, CEO of EAG. "I am looking forward to working with the staff of EAG Life Sciences, as we help our clients reach their product development goals" says Craig Morley.
EAG Life Sciences was acquired by Evans Analytical Group in April, 2011. The Company has deep experience in providing technical expertise and analysis of pharmaceutical and medical device products to enable their clients' successful movement through the stringent requirements and complex environment of the regulatory agencies.
